📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The validity of 18F-GE180 as a TSPO imaging agent. (2019)

First Author: Zanotti-Fregonara P

Attributed to: MRC Centre for Neurodevelopmental Disorders funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00259-019-4268-4

PubMed Identifier: 30656358

Publication URI: http://europepmc.org/abstract/MED/30656358

Type: Journal Article/Review

Volume: 46

Parent Publication: European journal of nuclear medicine and molecular imaging

Issue: 6

ISSN: 1619-7070